Progress in Percutaneous Penetration Enhancers from Traditional Chinese Medicines

doi:10.21127/yaoyimr20200008

Medicine Research ›› 2020, Vol. 4 ›› Issue (3): 200008-.DOI: 10.21127/yaoyimr20200008

Special Issue: Drug Delivery

• Minireviews • Next Articles

Progress in Percutaneous Penetration Enhancers from Traditional Chinese Medicines

Yingying Huang,^a Jinyu Yi,^a and Chaoyan Zhang*,^a,b,c,d

a College of Food Science and Technology, Shanghai Ocean University, Shanghai 201306, China
b Shanghai Engineering Research Center of Aquatic-Product Processing & Preservation, Shanghai 201306, China
c Laboratory of Quality and Safety Risk Assessment for Aquatic Product on Storage and Preservation (Shanghai), Ministry of Agriculture, Shanghai 201306, China
d Collaborative Innovation Center of Seafood Deep Processing, Dalian Polytechnic University, Dalian, Liaoning 116034, China

Received:2020-05-21 Revised:2020-08-13 Online:2020-09-22 Published:2020-09-22
Contact: chyzhang@shou.edu.cn (C. Z.)
Supported by:

Abstract

Abstract: Percutaneous penetration enhancers can regulate the transdermal absorption of drugs. Generally speaking, it can be divided into two categories: chemical synthesis and natural sources. Natural percutaneous penetration enhancers have the advantages of safety and mildness. This review summarizes the mechanism and characteristics of three kinds of percutaneous penetration enhancers and their combined application in transdermal drug delivery systems. The three different types of percutaneous penetration enhancers are fatty acids, alkaloids and terpenes. It is expected to provide considerations for the application research of percutaneous penetration enhancers rich in traditional Chinese medicines in transdermal drug delivery systems.

Key words: traditional Chinese medicines, percutaneous penetration enhancers, combined application

Yingying Huang, Jinyu Yi, Chaoyan Zhang. Progress in Percutaneous Penetration Enhancers from Traditional Chinese Medicines[J]. Medicine Research, 2020, 4(3): 200008-.

[1]	Carita Sallomy, Maija Lahtela-Kakkonen, and Juri M. Timonen. Recent Advances on Molecular Modeling Studies of Transient Receptor Potential Ankyrin 1 [J]. Medicine Research, 2021, 5(1): 200021-200021.
[2]	Titi Liu, Chengting Zi, Xuanjun Wang, Jun Sheng, and Huanhuan Xu. Recent Advances on Interaction Targets for Anticancer Activity of Caffeine [J]. Medicine Research, 2021, 5(1): 200020-200020.
[3]	Zhao Wang, Filipe Olim, Jingjing Sun, Ana Rute Neves, Fátima Mendes, Helena Tomás, and Ruilong Sheng. Prodrug Systems (II): A Perspective of Polymer-Based Doxorubicin Prodrug Systems towards Chemotherapy [J]. Medicine Research, 2021, 5(1): 200023-200023.
[4]	Xiu-Li Sun, Yin-Rong Xie, Ning Zhang, Cheng-Ting Zi, Xuan-Jun Wang, and Jun Sheng. Recent Advances on Small-Molecule Tubulin Inhibitors [J]. Medicine Research, 2021, 5(1): 200024-200024.
[5]	Zhonglie Yang, Li Lin, Xiaoyan Peng, Xinyi Yu, Xiaobin Zhang, Hezhong Jiang, and Jiahong Li. Adverse Reactions and Resistance of Anticancer Drug Cisplatin [J]. Medicine Research, 2021, 5(1): 200022-200022.
[6]	Jinyu Yi, Yingying Huang, and Chaoyan Zhang. Bletilla striata Polysaccharides: Structures and Functional Activities [J]. Medicine Research, 2020, 4(4): 200009-0.
[7]	Alessandra Campbell Pinheiro, Sarah Sant’Anna Maranhão, Guilherme Graziany Camelo Carvalho, Augusto César Aragão Oliveira, Cláudia Pessoa, Thaís Cristina Mendonça Nogueira, Cristiane França da Costa, Marcus Vinícius Nora de Souza. Synthesis and Cytotoxic Activity of Arenecarbaldehyde 2-Pyridinylhydrazone Derivatives [J]. Medicine Research, 2020, 4(4): 200016-200016.
[8]	Xiao-Jing Shen, Ting-Ting Zheng, Hong Wang, Jiao Cai, Cheng-Ting Zi, and Jiang-Ping Fan. Progress in Antitumor Activity of Diterpenoid Alkaloids [J]. Medicine Research, 2020, 4(4): 200015-200015.
[9]	Xiaodi Li, Rui Liu, Ping Wang, and Jun Zhu. An Effective Inhibitory of Triptolide on Ovarian Cancer [J]. Medicine Research, 2020, 4(4): 200017-200017.
[10]	Kuo Xu, Qian Liu, Lin Ni, Yong-Mei Du and Zhong-Feng Zhang. An Update on Chemical Constituents from Nicotiana tabacum L. and Their Bioactivities from 2017 to 2020 [J]. Medicine Research, 2020, 4(4): 200019-200019.
[11]	Hao Wang, Ji-Lei Liang, Qing-Ming He, Guo-Hai Zhou, Cun-Fu Li, Ping-He Wei, and Hao-Yan Dong. Flavonoids, Phenylethanoids and Phenylpropanoids from Rhodiola rosea L. and Their Lipid-Lowering Activities on Receptor 5-HT_2A [J]. Medicine Research, 2020, 4(4): 200018-200018.
[12]	. Contents: Med. Res. 4/2020 [J]. Medicine Research, 2020, 4(4): 0-0.
[13]	Xiaojing Shena , Weiwei Jiang. Polysaccharides from Bletilla striata: Extraction, Optimization and Their Antioxidant Activities in vitro [J]. Medicine Research, 2020, 4(3): 200010-.
[14]	Bo-Ya Shi, Ze-Hao Wang, Xuan-Jun Wang Jun Sheng, and Cheng-Ting Zi. Recent Advances on Small-Molecule Epidermal Growth Factor Receptor Inhibitors [J]. Medicine Research, 2020, 4(3): 200011-.
[15]	Shuyu Xu, Yin Qu, Xinyu Liu, Yao Li, Jimin Liu, Hezhong Jiang. Progress in Chemical Constituents and Pharmacological Effects of Citrus medica L. var. sarcodactylis Swingle [J]. Medicine Research, 2020, 4(1-2): 190014-190014.

Progress in Percutaneous Penetration Enhancers from Traditional Chinese Medicines

PDF

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics